首页> 外国专利> GPCR HETEROMER INHIBITORS AND THEIR USE

GPCR HETEROMER INHIBITORS AND THEIR USE

机译:GPCR异代抑制剂及其使用

摘要

Provided herein is a method for suppressing an enhanced downstream signaling from a CXCR4-GPCRx heteromer in a cell of a subject, wherein the method comprises administering to said subject a CXCR4 inhibitor and a GPCRx inhibitor; wherein: i) said CXCR4-GPCRx heteromer has an enhanced downstream signaling; and ii) said CXCR4 inhibitor and said GPCRx inhibitor suppress said enhanced downstream signaling from said CXCR4-GPCRx heteromer in said subject; wherein the enhanced downstream signaling is an enhanced amount of calcium mobilization; and wherein the method is not for treatment of the human or animal body by therapy. The suppression of said enhanced amount of calcium mobilization can lead to enhanced stem cell mobilization and the stem cell can be collected. Provided herein is also a stem cell collected by the method of the invention for use in a method of treating a pathological condition in a patient.
机译:本文提供了一种用于抑制来自受试者的细胞中的来自CXCR4-GPCRX异构体的增强的下游信号的方法,其中该方法包括向所述受试者施用CXCR4抑制剂和GPCRX抑制剂; 其中:i)表示CXCR4-GPCRX异构体具有增强的下游信号传导; II)表示CXCR4抑制剂和所述GPCRX抑制剂在所述受试者中抑制来自所述CXCR4-GPCRX异构体的所述增强的下游信号; 其中增强的下游信号传导是增强量的钙动员量; 并且其中该方法不用于通过治疗治疗人或动物体。 抑制所述增强量的钙动员可以导致增强的干细胞摩托,并且可以收集干细胞。 本文提供了通过本发明方法收集的干细胞,用于治疗患者的病理状况的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号